Ulcerated infantile hemangioma

  • Nídia Belo Pediatrics Department, Hospital do Espírito Santo de Évora
  • Patrícia Maio Pediatrics Department, Hospital do Espírito Santo de Évora
  • Susana Gomes Pediatrics Department, Hospital do Espírito Santo de Évora
  • Carla Cruz Pediatrics Department, Hospital do Espírito Santo de Évora
  • Maria João P. Lopes Dermatology Department, Centro Hospitalar Lisboa Central
Keywords: infantile hemangioma, propranolol, ulceration

Abstract

Infantile hemangiomas are the most frequent vascular tumors in pediatric age. Diagnostic can be challenging due to variable clinical presentation and natural history. Most cases have a favorable evolution. Treatment may be required according to tumor location, extension, and complications. Propranolol is an effective and safe treatment.
The case of an infant with perianal ulcerated hemangiomas treated with propranolol with clinical improvement is reported.

References

Ravenscroft J. Management of Infantile Haemangioma. Paediatrics and Child Health. 2014. 25:2.

Della Nina BI, Oliveira ZN, Machado MC, Macea JM. Apresentação, evolução e tratamento dos hemangiomas cutâneos - experiência do Ambulatório de Dermatologia Infantil do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. An Bras Dermatol. 2006;81(4):323-7.

Gontijo B, Silva CMR, Pereira LB. Hemangioma da Infancia. An Bras Dermatol. 2003;78(6):651-673.

A. Lanoel A, Tosi V, Bocian M, Lubieniecki F, Poblete SB, García HO, et al. Úlceras perianales sobre hemangioma con crecimiento mínimo o detenido segmentário. Actas Dermosifiliogr. 2012;103(9):820-3

Bonini FK, Bellodi FS, Souza EM. Hemangioma infantil tratado com propranolol. An Bras Dermatol. 20011;86(4):763-6

Hiraki PY, Goldenberg DC. Diagnóstico e tratamento do hemangioma infantil. Rev. Bras. Cir. Plást. 2010; 25(2): 388-97

Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference. Pediatrics. 2013. 131(1):128- 140

Lawley LP. Siegfried E, Todd JL. Propranolol Treatment for Hemangioma of Infancy: Risks and Recomendations. Pediatric Dermatology. 2009. 26(5): 610-4.

Melo IS, Gonçalves V, Anjos R. Propranolol nos hemangiomas infantis: casuística nacional com 30 doentes. Acta Pediatr Port 2012;43(5):190-4

Shah SD, Baselga E, McCuaig C, Pope E, Coulie J, Boon LM. Rebound growth of Infantile Hemangiomas After Propranolol Therapy. Pediatrics. 2016. 137(4): 1-8

Published
2019-04-11
Section
Case Reports